Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies
6.12.2025 12:31:00 CET | Business Wire | Press Release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/
Opening ceremony of Tengchong Scientists Forum on 6th December, 2025
Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development.
Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation projects. Organizers say the program reinforces the forum’s role as a platform linking scientific innovation with industry.
Several key publications and rankings were released for the first time, including the Technology Foresight and Future Vision Report, the Top 10 Technology Transfer Cases, Top 10 Academic Achievements, and Top 10 Science and Technology Cooperation Initiatives of 2025, highlighting the forum’s expanding academic influence.
A major highlight is the debut of the Tengchong Young Scientist Award, covering ten disciplines such as mathematics, physics, life sciences, materials science, ecology, aerospace and interdisciplinary arts and sciences. The award honors outstanding researchers under 40 who have made significant contributions to fundamental research or technological innovation.
The forum also draws on the legacy of the National Southwest Associated University, known for its spirit of resilience and excellence. Jointly organized by Peking University, Tsinghua University and Nankai University, the event includes a University Presidents Forum led by Peking University, where 77 university leaders explored strategies for integrated development in education, science and talent.
To strengthen global engagement, the forum invited more than 180 experts, scholars and business leaders from 26 countries. New outcomes related to Lancang–Mekong cooperation were also announced, linking to initiatives such as the “Wisdom Yunnan” program and the Lancang–Mekong National Science and Innovation Competition, which broaden opportunities for young scientists across South and Southeast Asia.
Organizers note that earlier editions of the forum established strong ties with global academic and industry communities and led to initiatives including the Declaration of the Tengchong Scientists Forum and the Tengchong Science Award, while facilitating numerous talent recruitment and investment projects.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251205499197/en/
Contacts
EncycloVision (Shenzhen) Brand Communication Co., Ltd.
Eason Zhou
evisionsinfo@gmail.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis3.3.2026 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory disease characterized by the development of multiple sterile pustules on the palms and soles. Patients often experience pain and pruritus of the skin, and the condition can be accompanied by nail involvement and joint pain. Because lesions on the palms are visible to others and lesions on the soles can cause pain while walking, daily functioning can be significantly restricted, leading in a substantial reduction in quality of life. PPP has a pathophysiology distinct from psoriasis and pustular psoriasis, and treatment can be challenging, unde
Yubico Establishes Singapore as Third Global Headquarters Accelerating Asia Pacific Growth3.3.2026 01:00:00 CET | Press Release
Yubico (NASDAQ STOCKHOLM: YUBICO), a cybersecurity company, inventor of FIDO passkeys and creator of the YubiKey, the most secure passkey, today announced the opening of its third global headquarters in Singapore. This announcement reinforces Yubico’s long-term commitment to the Asia Pacific region and builds on its role in advancing open authentication standards, while shaping a safer digital world for all. The new office complements Yubico’s existing global headquarters in Stockholm, Sweden and Santa Clara, USA, reflecting its strategy to serve a growing international user base by helping customers deploy YubiKeys at scale to adapt to a rapidly evolving cybersecurity landscape. “As the digital economy grows, there’s a decisive shift across Asia Pacific, where organizations are moving beyond legacy multi-factor authentication to meet rigorous new national regulations for identity protection,” said Jerrod Chong, Acting Chief Executive Officer at Yubico, a Singaporean. “The expansion of
IFF Completed the Divestiture of Soy Crush, Concentrates and Lecithin Businesses2.3.2026 22:15:00 CET | Press Release
IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its soy crush, concentrates and lecithin businesses to Bunge. This transaction does not include IFF’s soy isolates business. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2026 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20260302231096/en/
Verimatrix ReAccess Earns Gold 2026 Merit Award for Telecom & Wireless2.3.2026 17:50:00 CET | Press Release
Regulatory News: Verimatrix (Euronext Paris: VMX), a leading provider of security solutions for a safer connected world, today announced that its Verimatrix ReAccess solution was honored with a gold 2026 Merit Award for Telecom & Wireless. The industry accolade recognizes the company’s next-generation content security solution that modernizes legacy Conditional Access Systems (CAS) across DVB, IPTV and OTT networks without requiring costly hardware replacements or field service interventions. Judged by industry executives, media professionals and technology consultants, the Merit Awards evaluate submissions from across the telecommunications landscape. Verimatrix ReAccess enables secure, over-the-air (OTA) software updates to deployed set-top boxes (STBs), delivering operator cost savings, reduced operational complexity, and ongoing protection against piracy. It also empowers operators to continuously strengthen content security, eliminating the need for costly hardware replacements. U
Textron Aviation Launches Donation Campaign to Support 2026 Special Olympics Airlift; Continues Nationwide Call for Volunteer Doves2.3.2026 17:00:00 CET | Press Release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the launch of a donation campaign benefitting Special Olympics in support of the 2026 Special Olympics Airlift, a nationwide effort that brings athletes and coaches to the Special Olympics USA Games through the generosity of volunteer pilots, aircraft owners and operators known as Doves. Financial contributions go directly to the Special Olympics, a 501(c)(3) charitable organization. New for the 2026 event, the donation campaign serves a vital role in ensuring each delegation has what it needs for a smooth and welcoming travel experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302196418/en/ Textron Aviation launches donation campaign to support 2026 Special Olympics Airlift; continues nationwide call for volunteer Doves (Photo credit: Textron Aviation). “This campaign reflects the spirit of unity and generosity that defines the Special Olym
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom